During the American Urological Association (AUA) 2026 Annual Meeting, Benjamin Croll, MD, a Urologic Oncology Fellow at Fox Chase Cancer Center, explained to OncLive the importance of developing effective biomarkers in renal cell carcinoma.
During the American Urological Association (AUA) 2026 Annual Meeting, Benjamin Croll, MD, a Urologic Oncology Fellow at Fox Chase Cancer Center, explained to OncLive the importance of developing effective biomarkers in renal cell carcinoma.